泌尿器科学講座学術論文
学術論文 2010年～2020年
- Correcting imbalance of sex hormones by a phosphodiesterase 5 inhibitor improves copulatory dysfunction in male rats with type 2 diabetes. Itoga A, Zha X, Nagase K, Aoki Y, Ito H, Yokoyama O. BMJ Open Diabetes Res Care. 2020 May;8(1):e001111. doi: 10.1136/bmjdrc-2019-001111.
- Duration of smoking cessation is negatively associated with the magnitude of chronic prostatic inflammation and storage dysfunction in patients with benign prostatic hyperplasia: Inamura S, Ito H, Oe H, Seki M, Taga M, Kobayashi M, Yokoyama O. Int J Urol. 2020 Oct;27(10):874-881. doi: 10.1111/iju.14320. Epub 2020 Jul 24.
- Efficacy of vibegron, a novel β3-adrenoreceptor agonist, on severe urgency urinary incontinence related to overactive bladder: Post-hoc analysis of a randomized, placebo-controlled, double-blind comparative phase 3 study. Yoshida M, Takeda M, Gotoh M, Yokoyama O, Kakizaki H, Takahashi S, Masumori N, Nagai S, Minemura K. BJU Int. 2020 Jan 28. doi: 10.1111/bju.15020. [Epub ahead of print] PMID: 31991511
- OnabotulinumtoxinA (botulinum toxin type A) for the treatment of Japanese patients with overactive bladder and urinary incontinence: Results of single-dose treatment from a phase III, randomized, double-blind, placebo-controlled trial (interim analysis). Yokoyama O, Honda M, Yamanishi T, Sekiguchi Y, Fujii K, Nakayama T, Mogi T. Int J Urol. 2020 Jan 20. doi: 10.1111/iju.14176. [Epub ahead of print] PMID: 31957922
- Low-dose Docetaxel Enhanced the Anticancer Effect of Temsirolimus by Overcoming Autophagy in Prostate Cancer Cells. Inamura SO, Ito H, Taga M, Tsuchiyama K, Hoshino H, Kobayashi M, Yokoyama O. Anticancer Res. 2019 Oct;39(10):5417-5425. doi: 10.21873/anticanres.13735. PMID: 31570436
- Remarkable effect of presurgical nivolumab on originally inoperable papillary renal cell carcinoma with tumor thrombus in inferior vena cava. Shinagawa T, Ito H, Sakai Y, Mikami S, Oe H, Taga M, Yokoyama O. Int Cancer Conf J. 2019 Jun 18;8(4):170-174. doi: 10.1007/s13691-019-00379-1. eCollection 2019 Oct. PMID: 31559117
- Neurogenic bladder associated with xeroderma pigmentosum type A: A case report and literature review. Tsuchiyama K, Aoki Y, Ito H, Yoneda M, Yokoyama O. Urol Case Rep. 2019 Aug 20;27:100996. doi: 10.1016/j.eucr.2019.100996. eCollection 2019 Nov. PMID: 31467858
- Low and high body mass index values are associated with female nocturia. Ito H, Aoki Y, Oe H, Taga M, Tsuchiyama K, Yokoyama O. Neurourol Urodyn. 2019 Nov;38(8):2250-2254. doi: 10.1002/nau.24126. Epub 2019 Jul 23. PMID: 31338884
- Advanced bladder cancer with malignant psoas syndrome: A case report with a focus on physical findings and complications. Tsuchiyama K, Ito H, Seki M, Inai K, Yokoyama O. Urol Case Rep. 2019 Jul 2;26:100958. doi: 10.1016/j.eucr.2019.100958. eCollection 2019 Sep. PMID: 31321211
- α1 -Blocker inhibits non-voiding contractions and decreases the level of intravesical prostaglandin E2 in rats with partial bladder outlet obstruction. Akino H, Ito H, Nagase K, Matsuta Y, Aoki Y, Hattori T, Yokoyama O. Int J Urol. 2019 Sep;26(9):924-930. doi: 10.1111/iju.14069. Epub 2019 Jul 17. PMID: 31317581
- Role of corticotropin-releasing factor on bladder function in rats with psychological stress. Seki M, Zha XM, Inamura S, Taga M, Matsuta Y, Aoki Y, Ito H, Yokoyama O. Sci Rep. 2019 Jul 8;9(1):9828. doi: 10.1038/s41598-019-46267-9. PMID: 31285518
- Serum C-reactive protein level is not associated with prostatic inflammation but with overactive detrusor in patients with benign prostatic hyperplasia. Inamura S, Ito H, Shinagawa T, Tsutsumiuchi M, Taga M, Tsuchiyama K, Kobayashi M, Yokoyama O. Neurourol Urodyn. 2019 Aug;38(6):1728-1736. doi: 10.1002/nau.24051. Epub 2019 Jun 4. PMID: 31165507
- Preferential expression of sialyl 6′-sulfo N-acetyllactosamine-capped O-glycans on high endothelial venules in human peripheral lymph nodes. Tsutsumiuchi M, Hoshino H, Kogami A, Tsutsumiuchi T, Yokoyama O, Akama TO, Kobayashi M. Lab Invest. 2019 Oct;99(10):1428-1441. doi: 10.1038/s41374-019-0267-0. Epub 2019 May 31. PMID: 31148596
- Efficacy of novel β3 -adrenoreceptor agonist vibegron on nocturia in patients with overactive bladder: A post-hoc analysis of a randomized, double-blind, placebo-controlled phase 3 study. Yoshida M, Takeda M, Gotoh M, Yokoyama O, Kakizaki H, Takahashi S, Masumori N, Nagai S, Hashimoto K, Minemura K. Int J Urol. 2019 Mar;26(3):369-375. doi: 10.1111/iju.13877. Epub 2018 Dec 17. PMID: 30557916
- Long-term safety and efficacy of antimuscarinic add-on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A multicenter, randomized study in Japan (MILAI II study). Yamaguchi O, Kakizaki H, Homma Y, Igawa Y, Takeda M, Nishizawa O, Gotoh M, Yoshida M, Yokoyama O, Seki N, Okitsu A, Hamada T, Kobayashi A, Kuroishi K. Int J Urol. 2019 Mar;26(3):342-352. doi: 10.1111/iju.13868. Epub 2018 Dec 13. PMID: 30548692
- Therapeutic effect of propiverine hydrochloride on mixed-type urinary incontinence in women: The Female Urgency and Stress Urinary Incontinence Study of Propiverine Hydrochloride trial. Minagawa T, Gotoh M, Yokoyama O, Sugaya K, Yamanishi T, Kawahara K, Kaga K, Kikuchi T, Nishizawa O; FRESH study group. Int J Urol. 2018 May;25(5):486-491. doi: 10.1111/iju.13553. Epub 2018 Apr 12. PMID: 29651806
- Prostatic stromal inflammation is associated with bladder outlet obstruction in patients with benign prostatic hyperplasia. Inamura S, Ito H, Shinagawa T, Tsutsumiuchi M, Taga M, Kobayashi M, Yokoyama O. Prostate. 2018 Jul;78(10):743-752. doi: 10.1002/pros.23518. Epub 2018 Apr 2. PMID: 29608020
- Efficacy and safety of fesoterodine treatment for overactive bladder symptoms in elderly women with and without hypertension. Yokoyama O, Yamagami H, Hiro S, Hotta S, Yoshida M. Int J Urol. 2018 Mar;25(3):251-257. doi: 10.1111/iju.13499. Epub 2017 Dec 10. PMID: 29224251
- Early improvement of storage or voiding symptoms by tadalafil predicts treatment outcomes in patients with lower urinary tract symptoms from benign prostatic hyperplasia. Yokoyama O, Ozeki A, Suzuki N, Murakami M. Int J Urol. 2018 Mar;25(3):240-245. doi: 10.1111/iju.13487. Epub 2017 Nov 1. PMID: 29094398
- Castration increases PGE2 release from the bladder epithelium in male rats. Ito H, Wang D, Zha X, Inamura S, Seki M, Taga M, Yokoyama O. Life Sci. 2018 Jan 15;193:252-256. doi: 10.1016/j.lfs.2017.10.037. Epub 2017 Nov 8. PMID: 29080694
- Cost-Effectiveness Analysis of Long-Term Intermittent Self-Catheterization with Hydrophilic-Coated and Uncoated Catheters in Patients with Spinal Cord Injury in Japan. Watanabe T, Yamamoto S, Gotoh M, Saitoh T, Yokoyama O, Murata T, Takeda M. Low Urin Tract Symptoms. 2017 Sep;9(3):142-150. doi: 10.1111/luts.12122. Epub 2015 Nov 30. PMID: 28868661
- Clinical guidelines for male lower urinary tract symptoms and benign prostatic hyperplasia. Homma Y, Gotoh M, Kawauchi A, Kojima Y, Masumori N, Nagai A, Saitoh T, Sakai H, Takahashi S, Ukimura O, Yamanishi T, Yokoyama O, Yoshida M, Maeda K. Int J Urol. 2017 Oct;24(10):716-729. doi: 10.1111/iju.13401. Epub 2017 Jul 26. PMID: 28748576
- Clinicopathological implications to micropapillary bladder urothelial carcinoma of the presence of sialyl Lewis X-decorated mucin 1 in stroma-facing membranes. Shinagawa T, Hoshino H, Taga M, Sakai Y, Imamura Y, Yokoyama O, Kobayashi M. Urol Oncol. 2017 Oct;35(10):606.e17-606.e23. doi: 10.1016/j.urolonc.2017.06.004. Epub 2017 Jun 27. PMID: 28666720
- [Adult Male Ureterocele Detected by Urinary Frequency]. Kurokawa T, Kabuto T, Matsuta Y, Aoki Y, Ito H, Yokoyama O, Oyama N. Hinyokika Kiyo. 2017 May;63(5):207-210. doi: 10.14989/ActaUrolJap_63_5_207. Review. Japanese. PMID: 28625028
- Safety and efficacy of the combination of once-daily tadalafil and alpha-1 blocker in Japanese men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A randomized, placebo-controlled, cross-over study. Takeda M, Yokoyama O, Yoshida M, Nishizawa O, Hirata K, Nakaoka R, Takita Y, Murakami M. Int J Urol. 2017 Jul;24(7):539-547. doi: 10.1111/iju.13357. Epub 2017 May 26. PMID: 28556284
- Appearance of High Endothelial Venule-Like Vessels in Benign Prostatic Hyperplasia is Associated With Lower Urinary tract Symptoms. Inamura S, Shinagawa T, Hoshino H, Sakai Y, Imamura Y, Yokoyama O, Kobayashi M. Prostate. 2017 May;77(7):794-802. doi: 10.1002/pros.23319. Epub 2017 Feb 9. PMID: 28181681
- Nerve growth factor release from the urothelium increases via activation of bladder C-fiber in rats with cerebral infarction. Yokokawa R, Akino H, Ito H, Zha X, Yokoyama O. Neurourol Urodyn. 2017 Aug;36(6):1448-1455. doi: 10.1002/nau.23142. Epub 2016 Sep 27. PMID: 27676696
- α1D-Adrenoceptor blockade increases voiding efficiency by improving external urethral sphincter activity in rats with spinal cord injury. Ishida H, Yamauchi H, Ito H, Akino H, Yokoyama O. Am J Physiol Regul Integr Comp Physiol. 2016 Nov 1;311(5):R971-R978. doi: 10.1152/ajpregu.00030.2016. Epub 2016 Sep 7. PMID: 27605559
- Nocturnal Polyuria and Hypertension in Patients with Lifestyle Related Diseases and Overactive Bladder. Yokoyama O, Nishizawa O, Homma Y, Takeda M, Gotoh M, Kakizaki H, Akino H, Hayashi K, Yonemoto K; OASIS Project Group. J Urol. 2017 Feb;197(2):423-431. doi: 10.1016/j.juro.2016.08.087. Epub 2016 Aug 24. PMID: 27565397
- Long-Term Endoscopic Follow-Up of Patients with Chronic Radiation Proctopathy after Brachytherapy for Prostate Cancer. Ohtani M, Suto H, Nosaka T, Saito Y, Ozaki Y, Hayama R, Naito T, Takahashi K, Ofuji K, Matsuda H, Hiramatsu K, Nemoto T, Shioura H, Kimura H, Aoki Y, Yokoyama O, Nakamoto Y. Diagn Ther Endosc. 2016;2016:1414090. doi: 10.1155/2016/1414090. Epub 2016 Jun 9. PMID: 27378828
- Clinical Guideline for Female Lower Urinary Tract Symptoms. Takahashi S, Takei M, Nishizawa O, Yamaguchi O, Kato K, Gotoh M, Yoshimura Y, Takeyama M, Ozawa H, Shimada M, Yamanishi T, Yoshida M, Tomoe H, Yokoyama O, Koyama M. Low Urin Tract Symptoms. 2016 Jan;8(1):5-29. doi: 10.1111/luts.12111. Epub 2015 Oct 20. PMID: 26789539
- Tadalafil for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a review of clinical data in Asian men and an update on the mechanism of action. Yokoyama O, Igawa Y, Takeda M, Yamaguchi T, Murakami M, Viktrup L. Ther Adv Urol. 2015 Oct;7(5):249-64. doi: 10.1177/1756287215589238. Review. PMID: 26425140
- Underlying mechanisms of urine storage dysfunction in rats with salt-loading hypertension. Kurokawa T, Zha X, Ito H, Aoki Y, Akino H, Kobayashi M, Yokoyama O. Life Sci. 2015 Nov 15;141:8-12. doi: 10.1016/j.lfs.2015.09.010. Epub 2015 Sep 21. PMID: 26390819
- A potential role for 6-sulfo sialyl Lewis X in metastasis of bladder urothelial carcinoma. Taga M, Hoshino H, Low S, Imamura Y, Ito H, Yokoyama O, Kobayashi M. Urol Oncol. 2015 Nov;33(11):496.e1-9. doi: 10.1016/j.urolonc.2015.05.026. Epub 2015 Jun 29. PMID: 26137907
- [A case of metachronal testicular tumor eight years after medical treatment of extragonadal germ cell tumor]. Tanio M, Aoki Y, Kobayashi H, Yokoi S, Ito H, Oyama N, Akino H, Yokoyama O. Hinyokika Kiyo. 2015 Apr;61(4):173-6. Japanese. PMID: 26037678
- Once-daily oxybutynin patch improves nocturia and sleep quality in Japanese patients with overactive bladder: Post-hoc analysis of a phase III randomized clinical trial. Yokoyama O, Yamaguchi A, Yoshida M, Yamanishi T, Ishizuka O, Seki N, Takahashi S, Yamaguchi O, Higo N, Minami H, Masegi Y. Int J Urol. 2015 Jul;22(7):684-8. doi: 10.1111/iju.12755. Epub 2015 Mar 17. PMID: 25782032
- Effects of the 5α-reductase inhibitor dutasteride on rat prostate α1A-adrenergic receptor and its mediated contractility. Wang D, Zha X, Nagase K, Akino H, Muramatsu I, Ito H, Yokoyama O. Urology. 2015 Mar;85(3):704.e9-14. doi: 10.1016/j.urology.2014.12.002. PMID: 25733305
- Safety and efficacy of mirabegron as ‘add-on’ therapy in patients with overactive bladder treated with solifenacin: a post-marketing, open-label study in Japan (MILAI study). Yamaguchi O, Kakizaki H, Homma Y, Igawa Y, Takeda M, Nishizawa O, Gotoh M, Yoshida M, Yokoyama O, Seki N, Okitsu A, Hamada T, Kobayashi A, Kuroishi K. BJU Int. 2015 Oct;116(4):612-22. doi: 10.1111/bju.13068. Epub 2015 Apr 23. PMID: 25639296
- Add-on anticholinergic therapy for residual nocturia in patients with lower urinary tract symptoms receiving α1-blocker treatment: a multi-centre, prospective, randomised study. Yokoyama O, Tsujimura A, Akino H, Segawa N, Tamada S, Oguchi N, Kitagawa Y, Tsuji H, Watanabe A, Inamoto T, Shimizu N, Fujiuchi Y, Katsuoka Y, Azuma H, Matsuda T, Namiki M, Uemura H, Okuyama A, Nonomura N, Fuse H, Nakatani T. World J Urol. 2015 May;33(5):659-67. doi: 10.1007/s00345-014-1399-x. Epub 2014 Sep 16. PMID: 25224929
- Alpha 1-adrenoceptor blocker may improve not only voiding but also storage lower urinary tract symptoms caused by (125) I brachytherapy for prostate cancer. Oyama N, Aoki Y, Ito H, Miwa Y, Akino H, Sato Y, Shioura H, Kimura H, Yokoyama O. ISRN Urol. 2014 Mar 30;2014:140654. doi: 10.1155/2014/140654. eCollection 2014. PMID: 25006516
- [Two cases of epithelioid angiomyolipoma of the kidney]. Kaneda M, Ito H, Horie N, Taga M, Watanabe N, Tadakazu O, Imamura Y, Yokoyama O. Nihon Hinyokika Gakkai Zasshi. 2013 Nov;104(6):712-5. Japanese. PMID: 24564079
- Efficacy of fesoterodine on nocturia and quality of sleep in Asian patients with overactive bladder. Yokoyama O, Hiro S, Hotta S, Mogami S, Yamagami H. Urology. 2014 Apr;83(4):750-5. doi: 10.1016/j.urology.2013.12.008. Epub 2014 Feb 8. PMID: 24518285
- Phase III, randomised, double-blind, placebo-controlled study of the β3-adrenoceptor agonist mirabegron, 50 mg once daily, in Japanese patients with overactive bladder. Yamaguchi O, Marui E, Kakizaki H, Homma Y, Igawa Y, Takeda M, Nishizawa O, Gotoh M, Yoshida M, Yokoyama O, Seki N, Ikeda Y, Ohkawa S. BJU Int. 2014 Jun;113(6):951-60. doi: 10.1111/bju.12649. Epub 2014 Mar 17. PMID: 24471907
- Surgical treatment of adrenal gland metastasis originating from small cell carcinoma of the urinary bladder. Taga M, Ito H, Kusukawa N, Miwa Y, Akino H, Imamura Y, Yokoyama O. Case Rep Urol. 2013;2013:982787. doi: 10.1155/2013/982787. Epub 2013 Dec 8. PMID: 24383037
- Diagnosis of complex renal cystic masses and solid renal lesions using PET imaging: comparison of 11C-acetate and 18F-FDG PET imaging. Oyama N, Ito H, Takahara N, Miwa Y, Akino H, Kudo T, Okazawa H, Fujibayashi Y, Komatsu K, Tsukahara K, Yokoyama O. Clin Nucl Med. 2014 Mar;39(3):e208-14. doi: 10.1097/RLU.0000000000000287. PMID: 24217534
- Factors influencing patient satisfaction with antimuscarinic treatment of overactive bladder syndrome: results of a real-life clinical study. Akino H, Namiki M, Suzuki K, Fuse H, Kitagawa Y, Miyazawa K, Fujiuchi Y, Yokoyama O. Int J Urol. 2014 Apr;21(4):389-94. doi: 10.1111/iju.12298. Epub 2013 Oct 14. PMID: 24118296
- [A case on hemodialysis with castration-resistant prostate cancer which responded to combination chemotherapy with docetaxel and prednisolone]. Ito H, Inamura S, Taga M, Tsuchiyama K, Kusukawa N, Oyama N, Akino H, Yokoyama O. Gan To Kagaku Ryoho. 2013 Sep;40(9):1245-7. Japanese. PMID: 24047790
- Carbon-11-acetate positron emission tomography (PET), versus fluorine- 18 fluorodeoxyglucose PET and CT for the diagnosis of recurrent prostate cancer after radical prostatectomy in cases of prostate specific antigen of more than 1 to 3ng/mL. Oyama N, Ito H, Aoki Y, Miwa Y, Akino H, Kudo T, Okazawa H, Fujibayashi Y, Welch M, Yokoyama O. Hell J Nucl Med. 2013 May-Aug;16(2):146-7. No abstract available. PMID: 24032176
- Agonist pharmacology at recombinant α1A – and α1L -adrenoceptors and in lower urinary tract α1 -adrenoceptors. Yoshiki H, Uwada J, Umada H, Kobayashi T, Takahashi T, Yamakawa T, Yamaguchi A, Yokoyama O, Muramatsu I. Br J Pharmacol. 2013 Nov;170(6):1242-52. doi: 10.1111/bph.12403. PMID: 24024968
- Imidafenacin, an antimuscarinic agent, improves nocturia and reduces nocturnal urine volume. Yokoyama O, Homma Y, Yamaguchi O. Urology. 2013 Sep;82(3):515-20. doi: 10.1016/j.urology.2013.05.017. Epub 2013 Jul 19. PMID: 23876590
- [Successful treatment with docetaxel and prednisolone for paxlitaxel and carboplatin-resistant prostate cancer]. Kusukawa N, Ishida H, Tanase K, Ito H, Aoki Y, Ooyama N, Akino H, Yokoyama O. Hinyokika Kiyo. 2013 May;59(5):301-4. Japanese. PMID: 23719139
- Nocturia Potentially Influences Maintenance of Sexual Function in Elderly Men with Benign Prostatic Hyperplasia. Ishizuka O, Matsuyama H, Sakai H, Matsubara A, Nagaoka A, Takahashi S, Takeda M, Ozono S, Shiroki R, Shuin T, Hara I, Kakizaki H, Tsukamoto T, Yamanishi T, Yokoyama O, Kakehi Y, Nishizawa O; KING Study Group. Low Urin Tract Symptoms. 2013 May;5(2):75-81. doi: 10.1111/j.1757-5672.2012.00173.x. Epub 2012 Sep 21. PMID: 26663374
- Drugs interacting with organic anion transporter-1 affect uptake of Tc-99m-mercaptoacetyl-triglycine (MAG3) in the human kidney: therapeutic drug interaction in Tc-99m-MAG3 diagnosis of renal function and possible application of Tc-99m-MAG3 for drug development. Takahara N, Saga T, Inubushi M, Kusuhara H, Seki C, Ito S, Oyama N, Yokoyama O, Sugiyama Y, Fujibayashi Y. Nucl Med Biol. 2013 Jul;40(5):643-50. doi: 10.1016/j.nucmedbio.2013.03.006. Epub 2013 Apr 22. PMID: 23618840
- Antidiuretic effect of antimuscarinic agents in rat model depends on C-fibre afferent nerves in the bladder. Watanabe N, Akino H, Kurokawa T, Taga M, Yokokawa R, Tanase K, Nagase K, Yokoyama O. BJU Int. 2013 Jul;112(1):131-6. doi: 10.1111/j.1464-410X.2012.11747.x. Epub 2013 Feb 22. PMID: 23432937
- Expression of microRNAs associated with Gleason grading system in prostate cancer: miR-182-5p is a useful marker for high grade prostate cancer. Tsuchiyama K, Ito H, Taga M, Naganuma S, Oshinoya Y, Nagano K, Yokoyama O, Itoh H. Prostate. 2013 Jun;73(8):827-34. doi: 10.1002/pros.22626. Epub 2012 Nov 26. PMID: 23184537
- Tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a randomized placebo- and tamsulosin-controlled 12-week study in Asian men. Yokoyama O, Yoshida M, Kim SC, Wang CJ, Imaoka T, Morisaki Y, Viktrup L. Int J Urol. 2013 Feb;20(2):193-201. doi: 10.1111/j.1442-2042.2012.03130.x. Epub 2012 Sep 7. PMID: 22958078
- Monoclonal antibody RM2 as a potential ligand for a new immunotracer for prostate cancer imaging. Hasegawa Y, Oyama N, Nagase K, Fujibayashi Y, Furukawa T, Murayama Y, Arai Y, Saito S, Welch MJ, Yokoyama O. Nucl Med Biol. 2012 Oct;39(7):944-7. doi: 10.1016/j.nucmedbio.2012.05.008. Epub 2012 Jul 4. PMID: 22766258
- IPSS is lower in hypertensive patients treated with angiotensin-II receptor blocker: posthoc analyses of a lower urinary tract symptoms population. Ito H, Taga M, Tsuchiyama K, Akino H, Yokoyama O. Neurourol Urodyn. 2013 Jan;32(1):70-4. doi: 10.1002/nau.22267. Epub 2012 Jun 12. PMID: 22693136
- Male Lower Urinary Tract Symptoms: Hypertension as a Risk Factor for Storage Symptoms, but Not Voiding Symptoms. Ito H, Yoshiyasu T, Yamaguchi O, Yokoyama O. Low Urin Tract Symptoms. 2012 May;4(2):68-72. doi: 10.1111/j.1757-5672.2011.00115.x. Epub 2011 Dec 28. PMID: 26676528
- Metabolic Syndrome and Nocturia. Aoki Y, Yokoyama O. Low Urin Tract Symptoms. 2012 Mar;4 Suppl 1:11-5. doi: 10.1111/j.1757-5672.2011.00118.x. PMID: 26676694
- [PET, PET-CT]. Oyama N, Yokoyama O. Nihon Rinsho. 2011 Jun;69 Suppl 5:280-4. Review. Japanese. No abstract available. PMID: 22207986
- [Advanced sarcomatoid renal cell carcinoma effectively treated with sunitinib: report of a case]. Tsuchiyama K, Ito H, Ishida H, Itoh H, Yokoyama O. Hinyokika Kiyo. 2011 Nov;57(11):615-8. Japanese. PMID: 22166824
- Outline of JUA clinical guidelines for benign prostatic hyperplasia. Homma Y, Gotoh M, Yokoyama O, Masumori N, Kawauchi A, Yamanishi T, Ishizuka O, Seki N, Kamoto T, Nagai A, Ozono S; Japanese Urological Association. Int J Urol. 2011 Nov;18(11):741-56. doi: 10.1111/j.1442-2042.2011.02860.x. PMID: 22050351
- Co-administration of an α(1) -blocker improves the efficacy and safety of antimuscarinic agents in rats with detrusor overactivity. Nagase K, Ito H, Aoki Y, Tanase K, Akino H, Yokoyama O. Int J Urol. 2011 Dec;18(12):836-43. doi: 10.1111/j.1442-2042.2011.02868.x. Epub 2011 Oct 13. PMID: 21995543
- Urethral Sensations are Related to the Development of Detrusor Overactivity. Yokoyama O, Miwa Y, Oyama N, Aoki Y, Ito H, Tanase K, Ishida H, Matsuta Y, Kusukawa N, Yamauchi H, Takahara N, Watanabe N, Tsuchiyama K, Yokoi S, Akino H. Low Urin Tract Symptoms. 2011 Sep;3(2):59-63. doi: 10.1111/j.1757-5672.2011.00096.x. Epub 2011 Jun 2. PMID: 26676387
- Assessment of Therapeutic Effect of Sunitinib by (11)C-Acetate PET Compared with FDG PET Imaging in a Patient with Metastatic Renal Cell Carcinoma. Oyama N, Takahara N, Hasegawa Y, Tanase K, Miwa Y, Akino H, Okazawa H, Kudo T, Fujibayashi Y, Yokoyama O. Nucl Med Mol Imaging. 2011 Sep;45(3):217-9. doi: 10.1007/s13139-011-0084-x. Epub 2011 May 20. PMID: 24900007
- Responsiveness and minimal clinically important change in overactive bladder symptom score. Gotoh M, Homma Y, Yokoyama O, Nishizawa O. Urology. 2011 Oct;78(4):768-73. doi: 10.1016/j.urology.2011.06.020. PMID: 21855969
- Efficacy of solifenacin on nocturia in Japanese patients with overactive bladder: impact on sleep evaluated by bladder diary. Yokoyama O, Yamaguchi O, Kakizaki H, Itoh N, Yokota T, Okada H, Ishizuka O, Ozono S, Gotoh M, Sugiyama T, Seki N, Yoshida M, Yamada S. J Urol. 2011 Jul;186(1):170-4. doi: 10.1016/j.juro.2011.02.2700. Epub 2011 May 14. PMID: 21575976
- Antimuscarinics suppress adenosine triphosphate and prostaglandin E2 release from urothelium with potential improvement in detrusor overactivity in rats with cerebral infarction. Yokoyama O, Tanaka I, Kusukawa N, Yamauchi H, Ito H, Aoki Y, Oyama N, Miwa Y, Akino H. J Urol. 2011 Jun;185(6):2392-7. doi: 10.1016/j.juro.2011.02.048. Epub 2011 Apr 21. PMID: 21511278
- Randomized Controlled Trial to Treat Benign Prostatic Hyperplasia with Overactive Bladder Using an Alpha-blocker Combined with Anticholinergics. Nishizawa O, Yamaguchi O, Takeda M, Yokoyama O; TAABO Study Group. Low Urin Tract Symptoms. 2011 Apr;3(1):29-35. doi: 10.1111/j.1757-5672.2010.00081.x. Epub 2010 Sep 20. PMID: 26676349
- [Combination chemotherapy of paclitaxel, carboplatin and gemcitabine in patients who have received prior cisplatin-based chemotherapy]. Ito H, Aoki Y, Oyama N, Miwa Y, Akino H, Yokoyama O. Gan To Kagaku Ryoho. 2011 Mar;38(3):481-4. Review. Japanese. PMID: 21403460
- Propiverine hydrochloride in Japanese patients with overactive bladder: a randomized, double-blind, placebo-controlled trial. Gotoh M, Yokoyama O, Nishizawa O; Japanese Propiverine Study Group. Int J Urol. 2011 May;18(5):365-73. doi: 10.1111/j.1442-2042.2011.02732.x. Epub 2011 Feb 20. PMID: 21332825
- Modulation of stretch evoked adenosine triphosphate release from bladder epithelium by prostaglandin E₂. Tanaka I, Nagase K, Tanase K, Aoki Y, Akino H, Yokoyama O. J Urol. 2011 Jan;185(1):341-6. doi: 10.1016/j.juro.2010.09.042. PMID: 21075387
- Effect of corticotropin-releasing factor receptor antagonist on psychologically suppressed masculine sexual behavior in rats. Miwa Y, Nagase K, Oyama N, Akino H, Yokoyama O. J Sex Med. 2011 Mar;8(3):688-95. doi: 10.1111/j.1743-6109.2010.02055.x. Epub 2010 Oct 4. PMID: 20946165
- Early response assessment in prostate carcinoma by ¹⁸F-fluorothymidine following anticancer therapy with docetaxel using preclinical tumour models. Oyama N, Hasegawa Y, Kiyono Y, Kobayashi M, Fujibayashi Y, Ponde DE, Dence C, Welch MJ, Yokoyama O. Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):81-9. doi: 10.1007/s00259-010-1613-z. Epub 2010 Sep 29. PMID: 20878403
- Urinary prostaglandin E₂ was increased in patients with suprapontine brain diseases, and associated with overactive bladder syndrome. Yamauchi H, Akino H, Ito H, Aoki Y, Nomura T, Yokoyama O. Urology. 2010 Nov;76(5):1267.e13-9. doi: 10.1016/j.urology.2010.06.012. Epub 2010 Aug 30. PMID: 20800884
- [Investigation of urinary management after removal of indwelling urethral catheters in a general hospital: associations between bedridden state and impaired bladder emptying]. Tsuchiyama K, Ueki O, Minami H, Kawaguchi K, Aoki Y, Yokoyama O. Hinyokika Kiyo. 2010 Jun;56(6):305-9. Japanese. PMID: 20610921
- Melatonin increases bladder capacity via GABAergic system and decreases urine volume in rats. Matsuta Y, Yusup A, Tanase K, Ishida H, Akino H, Yokoyama O. J Urol. 2010 Jul;184(1):386-91. doi: 10.1016/j.juro.2010.03.002. Epub 2010 May 20. PMID: 20488476
- Clinical guidelines for nocturia. Committee for Establishment of the Clinical Guidelines for Nocturia of the Neurogenic Bladder Society. Int J Urol. 2010 May;17(5):397-409. doi: 10.1111/j.1442-2042.2010.02527.x. PMID: 20415705
- Composite paraganglioma with ganglioneuroma in the retroperitoneal space. Ito H, Kurokawa T, Yokoyama O. Int J Urol. 2010 Apr;17(4):385-6. doi: 10.1111/j.1442-2042.2010.02474.x. No abstract available. PMID: 20409235
- α(1)-adrenoceptor blocker naftopidil improves sleep disturbance with reduction in nocturnal urine volume. Yokoyama O, Aoki Y, Tsujimura A, Takao T, Namiki M, Okuyama A. World J Urol. 2011 Apr;29(2):233-8. doi: 10.1007/s00345-010-0544-4. Epub 2010 Apr 13. PMID: 20387069
- Influence of Urethral Sphincter Incompetence on Bladder Shape and Function in Myelodysplastic Children. Yokoyama O, Ito H, Namiki M. Low Urin Tract Symptoms. 2010 Apr;2(1):27-30. doi: 10.1111/j.1757-5672.2010.00056.x. Epub 2010 Jan 29. PMID: 26676216
- Selective α1A-blocker improves bladder storage function in rats via suppression of C-fiber afferent activity. Yokoyama O, Ito H, Aoki Y, Oyama N, Miwa Y, Akino H. World J Urol. 2010 Oct;28(5):609-14. doi: 10.1007/s00345-009-0481-2. Epub 2009 Oct 16. PMID: 19834713
- Zolpidem increases bladder capacity and decreases urine excretion in rats. Yokoyama O, Matsuta Y, Yanai-Inamura H, Watanabe M, Ohtake A, Suzuki M, Sasamata M. Neurourol Urodyn. 2010 Apr;29(4):587-91. doi: 10.1002/nau.20797. PMID: 19760758
- 伊藤 秀明, 青木 芳隆, 大山 伸幸, 三輪 吉司, 秋野 裕信, 横山 修: MVAC抵抗性進行・再発尿路上皮癌に対するPaclitaxel/Carboplatin/Gemcitabine併用化学療法の検討. 癌と化学療法, 38（3）, 481-4, 2011.03
- 伊藤 秀明, 秋野 裕信, +細川 高志, +吉田 浩士, +岩堀 嘉郎, +守山 典宏, +藤田 知洋, +中村 直博, +三原 信也, +平田 昭夫, +塚原 健治, +菅田 敏明, +福島 克冶, 横山 修: 過活動膀胱治療薬の変更が患者の薬に対する印象や満足度に与える影響. 泌尿器外科, 23（12）, 1751-1758, 2010.12
- 土山 克樹, +上木 修, +南 秀朗, +川口 光平, 青木 芳隆, 横山 修: 尿道留置カテーテル離脱にむけた急性期病院での排尿管理の検討. 泌尿紀要, 56（6）, 305-309, 2010.06（症例報告）
- 大山 伸幸, 横山 修: 泌尿器科疾患の診断におけるＰＥＴの役割. Annual Review 腎臓, 78-83, 2010.01